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Background. Both dobutamine stress echocardiography (DSE) and myocardial perfusion
imaging (MPI) using single-photon emission computed tomography (SPECT) are frequently
used for cardiac risk stratification. The long-term relative prognostic value of these modalities
has not been studied. Therefore, this study evaluated the long-term prognostic value of DSE
compared to MPI in patients unable to perform exercise testing.
Methods. This prospective, single center study included 301 patients (mean age
59 ± 12 years, 56% men) unable to perform exercise tests who underwent DSE and dobutamine
stress 99mTc-sestamibi MPI. End points during follow-up were all-cause mortality, cardiac
mortality, and nonfatal myocardial infarction (MI). Univariable and multivariable Cox pro-
portional hazards regression models were used to identify independent predictors of outcome.
The probability of survival was calculated using the Kaplan-Meier method.
Results. A total of 182 patients (60%) had an abnormal DSE and 198 (66%) patients had an
abnormal MPI. The agreement between DSE and MPI was 82% (j 5 0.62). During a median
follow-up of 14 years (range 5-18), 172 deaths (57%) occurred, of which 72 (24%) were due to
cardiac causes. Nonfatal MI occurred in 46 patients (15%). The multivariable analysis
demonstrated that an abnormal DSE was a significant predictor of cardiac mortality (HR 2.35,
95% CI [1.17-4.73]) and hard cardiac events (HR 2.11, 95% CI [1.25-3.57]). Also, an abnormal
MPI result was a significant predictor of cardiac mortality (HR 3.03, 95% CI [1.33-6.95]) and
hard cardiac events (HR 2.06, 95% CI [1.12-3.79]).
Conclusions. DSE and MPI are comparable in predicting long-term cardiac mortality and
hard cardiac events in patients unable to perform exercise testing. (J Nucl Cardiol 2018;25:471–9.)
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Abbreviations
CAD Coronary artery disease
C-statistic Concordance statistic
DSE Dobutamine stress echocardiography
ECG Electrocardiography
LVEF Left ventricular ejection fraction
MBq Megabecquerel
MI Myocardial infarction
MPI Myocardial perfusion imaging
SPECT Single-photon emission computed
tomography
99mTc Technetium-99m
INTRODUCTION
Coronary artery disease (CAD) remains a leading
cause of morbidity and mortality worldwide. As such, non-
invasive imaging techniques are important to diagnose and
risk stratify patients with CAD.1 In patients who cannot
exercise, due to conditions such as degenerative joint
disease and peripheral vascular disease, pharmacologic
stress testing is an appropriate alternative. Both dobu-
tamine stress echocardiography (DSE) and stress
myocardial perfusion imaging (MPI) are widely used for
the evaluation of stress-induced myocardial ischemia, and
provide significant prognostic information.2-7 Currently,
information on the long-term relative prognostic value of
DSE compared to MPI is lacking. Therefore, this study
evaluated the long-term prognostic value of DSE com-
pared to MPI in patients unable to perform exercise testing.
METHODS
Study Population
The study population consisted of 354 consecutive patients.
This study is a continuation of the previously reported study in
which the same patient population was evaluated with a mean
follow-up of 7.3 years.3 All patients underwent simultaneous
dobutamine stress echocardiography and dobutamine stress
99mTc-sestamibi SPECT for the evaluation of suspected or known
CAD. Follow-up was successful in 351 (99%) patients. Fifty
patients underwent early coronary revascularization \60 days
after MPI and were excluded from analysis. This exclusion was
based on previously published data indicating that referral to
coronary revascularization in the first 60 days after testing tends
to be based on the results of the test. Referral to revascularization
[60 days after testing tends to be based on the worsening of the
patient’s clinical status.8 All patients gave informed consent
before testing and the local ethics committee approved the study
protocol. Patients were enrolled between January 1991 and
January 1995. The test in these patients with known or suspected
CAD was requested for evaluation of ischemia. Before the stress
test, a structured interview was achieved, including assessment of
cardiac risk factors. Hypertension was defined as blood pressure
C140/90 mmHg or the use of antihypertensive medication.
Diabetes mellitus was defined as a fasting glucose level[140 mg/
dL or use of insulin or oral hypoglycemic agents. Hypercholes-
terolemia was defined as a total cholesterol C6.4 mmol/L or
treatment with lipid-lowering medication.
Dobutamine Stress Testing Protocol
The dobutamine stress testing was performed using a
standard protocol as described previously.3 Dobutamine was
injected intravenously, starting at a dose of 10 lg/kg/min for
3 min and increasing by 10 lg/kg/min to a maximum dose of
40 lg/kg/min. If the test end point was not reached at a maximum
dose of dobutamine, up to 1 mg of atropine was administered
intravenously. During stress testing, blood pressure, heart rate, and
electrocardiography were continuously monitored. Test endpoints
were achievement of target heart rate (85% of maximum age and
sex-predicted heart rate), horizontal or downsloping ST-segment
depression of more than 2 mm, ST-segment elevation of more
than 1 mm, severe angina, systolic blood pressure decrease
[40 mmHg, blood pressure [240/110 mmHg, or clinically
important cardiac arrhythmias. An intravenous beta-blocker was
used to reverse the effects of dobutamine/atropine.
99mTc-Sestamibi SPECT MPI
An intravenous dose of 370 MBq of 99mTc-sestamibi was
administered approximately 1 minute before the termination of
the stress test. For resting studies, 370 MBq of 99mTc-sestamibi
was injected C24 hours after the stress study. Image acquisition
was achieved with a Gammasonics single-head camera (Sie-
mens, Iselin, NJ) without attenuation or scatter correction,
using a low-energy all-purpose collimator. In all cases,
transaxial tomograms were reconstructed; for each study, six
short-axis and three sagittal long-axis slices were analyzed. To
compare the rest and stress studies, each of the short-axis slides
was divided into eight equal segments. The septal part of the
two basal slices was excluded from analysis because this region
corresponds to the fibrous portion of the interventricular septum
and normally exhibits reduced uptake. The apical region was
assessed from the three sagittal cross sections. A total of 47
segments per patient were analyzed. Data interpretation was
performed visually and semiquantitatively. Circumferential
profile analysis was used to assist visual analysis of images.
Stress and rest tomographic views were reviewed side-by-
side by two experienced observers who were unaware of
clinical data and echocardiograms, using a 5-point scoring
system (1 = normal, 2 = slightly reduced, 3 = moderately
reduced, 4 = severely reduced, 5 = absent uptake). Ischemia
was defined as a perfusion defect on stress images that partially
or completely resolved at rest in at least two contiguous
segments. A region was classified as infarcted in the case of a
See related editorial, pp. 480–482
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perfusion defect on stress images in two or more contiguous
segments, which persisted on rest images. An abnormal scan
was considered in the presence of a fixed or reversible
perfusion defect. To overcome misalignment between the
myocardial perfusion data and the echocardiographic data, an
identical six-segment model was used for both techniques. The
16 echocardiographic and 47 scintigraphic segments were
regrouped into six major myocardial regions (anterior, septum
anterior, septum inferior, inferoposterior, lateral, and apical).
Dobutamine Stress Echocardiography
Two-dimensional echocardiograms were acquired at rest,
during dobutamine stress testing, and during recovery. Two
experienced observers, unaware of any other data, scored the
echocardiograms using a standard 16-segment model. Regional
wall motion and systolic wall thickening were scored on a 5-
point scale (1 = normal, 2 = mild hypokinesia, 3 = severe
hypokinesia, 4 = akinesia, 5 = dyskinesia). Ischemia was
defined as new or worsened wall motion abnormalities during
stress, indicated by an increase in wall motion score ofC1 grade
in one or more segments. Ischemia was not considered to be
present when akinetic segments at rest became dyskinetic during
stress. Dobutamine stress echocardiographic results were
defined as abnormal if there was ischemia during stress or fixed
wall motion abnormalities. Echocardiographic segments were
grouped into six major segments for comparison with SPECT.9
Tests that were stopped prematurely in the absence of perfusion
or wall motion abnormalities were considered negative.
Follow-Up
Clinical outcome data were obtained in 2012 by contact-
ing the patient, the patients’ general practitioners, civil
registries, and reviewing hospital records. The date of the last
review or consultation was used to calculate follow-up time.
The endpoints were all-cause mortality, cardiac mortality, and
nonfatal myocardial infarction (MI). Cardiac mortality was
defined as death caused by MI, cardiac arrhythmias, refractory
heart failure, or sudden death occurring without another
explanation. The combined endpoint of cardiac mortality and
nonfatal MI was considered as hard cardiac events. MI was
defined according to the Joint European Society of Cardiology/
American College of Cardiology Committee criteria.10 Diag-
nosis of an acute, evolving, or recent MI was fulfilled either by
a typical rise and gradual fall (troponin) or more rapid rise and
fall (creatinine kinase-MB) of biochemical markers of myocar-
dial necrosis with at least one of the following criteria:
ischemic symptoms, development of pathological Q waves on
the electrocardiogram, electrocardiogram changes indicative of
myocardial ischemia (ST-segment elevation or depression), or
coronary artery intervention; or by pathological findings of an
acute MI.
Statistical Analysis
Values were expressed as means (±SD) or number, and
compared using the Student t-test or Chi-squared test.
Agreement between DSE and MPI was assessed by j statistics.
Univariable and multivariable Cox proportional hazard models
were used to identify variables that were independently
predictive of late cardiac events. The risk of a variable was
expressed as hazard ratios with corresponding 95% confidence
intervals. Clinical data, stress test variables, and non-invasive
imaging data were incorporated into the analysis. The multi-
variable analysis was performed by first considering the
clinical data, and next the combination of clinical and stress
test variables. In the final models, the stress echocardiographic
or 99mTc-sestamibi SPECT data were added. The discrimina-
tive ability of the Cox regression models was determined by
calculating the concordance (C)-index. Models are typically
considered reasonable when the C-index [0.7.11 The proba-
bility of survival was calculated using the Kaplan-Meier
method, and survival curves were compared using the log-rank
test. P-values\.05 were considered statistically significant. All
statistical analyses were performed using SPSS 22 (IBM Corp.,
Armonk, NY, USA).
RESULTS
Patient Demographics and Stress Test
Results
The clinical characteristics are presented in Table 1.
The mean age of the 301 patients was 59 ± 12 years,
and 56% were men. A total of 149 patients (50%) had a
previous MI. During the dobutamine-atropine stress test,
heart rate increased from a mean (±SD) of 69 ± 13 beats
per minute to 136 ± 17 beats per minute (P\ .0001),
and systolic blood pressure increased from
136 ± 23 mm Hg to 147 ± 30 mm Hg (P\ .001).
Atropine, which was added in 129 patients (43%), was
more frequently administered in patients taking beta-
blockers (67% (84/125]) than in those who were not
(26% (45/176], P\ .0001). Side effects during stress
testing included non-sustained ventricular tachycardia in
13 patients (4%), atrial fibrillation in 4 patients (1%),
severe hypotension in 2 patients (0.7%), nausea in 15
patients (5%), and headache in 15 patients (5%). No
patient experienced a MI or fatal complication. The test
was terminated because of side effects in 17 patients
(6%).
Imaging Results and Follow-Up
Abnormal DSE was detected in 182 (60%) patients,
whereas 198 (66%) patients had an abnormal MPI. The
agreement between DSE and MPI was 82% (j = 0.62).
When considered the 152 patients without previous MI
the agreement between DSE and MPI was 81%
(j = 0.60). The agreement between DSE and MPI was
86% (j = 0.36) when only ischemia was considered.
Normal DSE and abnormal MPI were observed in 35
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patients, whereas 19 patients had a normal MPI and an
abnormal DSE. During a median follow-up of 14 years
(range 5-18), 172 deaths (57%) occurred, of which 72
(24%) were due to cardiac causes. Nonfatal MI occurred
in 46 patients (15%).
Clinical Data and Outcome
Univariable predictors of both endpoints (cardiac
mortality and hard cardiac events) were age, male
gender, previous MI, heart failure, and ST-segment
changes (Table 1). When analyzed as a dichotomous
variable age was not a significant predictor. Smoking
was also a significant predictor of cardiac mortality.
Both an abnormal DSE and an abnormal MPI were
strongly associated with both endpoints.
Survival Analysis and Predictors of Long-
Term Outcome
Annualized event rates for cardiac mortality for
patients with normal DSE was significantly lower
(0.8%) than for those with abnormal DSE (2.8%,
P\ .001). According to hard cardiac events, annualized
event rates for normal DSE were 1.5% compared to
3.8% in abnormal DSE (P\ .001). Equally, the annu-
alized event rates for cardiac mortality for patients with
normal MPI was significantly lower than for those with
abnormal MPI (0.6% vs 2.8%, P\ .001). The annual-
ized rates for hard cardiac events were 1.3% in normal
MPI and 3.7% in abnormal MPI (P\ .001).
Kaplan-Meier survival curves are presented in
Figures 1, 2, and 3. The survival curves show that a
normal DSE and a normal MPI were associated with
relatively low risk for all-cause mortality, cardiac
mortality, and hard cardiac events. Conversely, patients
with an abnormal test result had a significantly increased
risk of all-cause mortality (Figure 1), cardiac mortality
(Figure 2) and hard cardiac events (Figure 3???). The
survival curves continued to diverge during the long-
term follow-up period, which indicated a maintained
prognostic value of both imaging modalities.
Multivariable analysis demonstrated that age, pre-
vious MI, smoking, and heart failure were independent
predictors of cardiac mortality (Table 2). Previous MI
and heart failure were independent predictors of hard
cardiac events (Table 2). Age was of borderline signif-
icance. A multivariable model also revealed that both an
abnormal DSE and an abnormal MPI had an incremental
prognostic value over clinical variables and stress test
parameters. For the prediction of cardiac mortality, the
C-index for clinical and clinical and stress test data was
0.73 and 0.76, respectively. The C-index was 0.76 when
DSE or MPI was added. For the prediction of hard
cardiac events, the C-index for clinical and clinical and
stress test data was 0.70 and 0.71, respectively and 0.71
when DSE or MPI were added.
DISCUSSION
The present study is the first to assess the prognostic
value of DSE compared to MPI for long-term outcome.
Table 1. Clinical characteristics
Variable (number
and %)
Total
Cardiac
mortality
No cardiac
mortality P-
value
Cardiac
events
No cardiac
events P-
valueN 5 301 N 5 72 N 5 229 N 5 118 N 5 183
Clinical data
Age[70 years 55 (18) 22 (31) 33 (14) .65 23 (19) 32 (17) .38
Male gender 168 (56) 50 (69) 118 (52) .01 79 (67) 89 (49) .002
Previous MI 149 (50) 51 (71) 98 (43) \.001 79 (34) 70 (38) \.001
Hypertension 132 (44) 34 (47) 98 (43) .49 54 (46) 78 (43) .45
Hypercholesterolemia 76 (25) 23 (32) 53 (23) .21 34 (29) 42 (23) .27
Smoking 79 (26) 26 (36) 53 (23) .03 34 (29) 45 (25) .42
Heart failure 57 (19) 26 (36) 31 (14) \.001 30 (25) 27 (15) .003
Diabetes mellitus 43 (14) 14 (19) 29 (13) .16 19 (16) 24 (13) .55
Stress test results
Typical angina 72 (24) 16 (22) 56 (24) .69 33 (28) 39 (21) .21
ST-segment changes 85 (28) 31 (43) 54 (24) .001 47 (21) 38 (21) .001
Abnormal DSE 182 (60) 59 (82) 123 (54) \.001 92 (78) 90 (49) \.001
Abnormal MPI 198 (66) 62 (86) 136 (59) \.001 97 (82) 101 (55) \.001
MI, myocardial infarction; DSE dobutamine stress echocardiography; MPI myocardial perfusion imaging
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During a median follow-up of 14 years, 172 deaths
occurred, of which 72 were due to cardiac causes.
Nonfatal MI occurred in 46 patients. The survival curves
continued to diverge during the follow-up period,
indicating a maintained prognostic value of both DSE
and MPI. Both patients with a normal DSE and a normal
MPI had a relatively favorable long-term prognosis in
contrast to patients with an abnormal imaging result. A
multivariable model revealed that both an abnormal
DSE and an abnormal MPI had an incremental prog-
nostic value over clinical variables and stress test
parameters. Ischemia on DSE but not ischemia on MPI
was predictive of outcome. Both modalities were com-
parable in identifying patients with low or high risk of
cardiac events during long-term follow-up.
Non-invasive imaging techniques are central in
diagnosing patients with known of suspected CAD. Both
DSE and MPI play important roles in this regard, in
particular in patients with an intermediate likelihood of
CAD,12 and show similar accuracy in the diagnosis of
CAD.5,6 Data on the long-term prognostic implications
of these imaging techniques are lacking.13
A few previous studies have compared the prog-
nostic value between DSE and MPI with a mean follow-
up time of less than 8 years.2,3,5-7,14,15 Geleijnse et al2
studied 220 patients with chest pain undergoing DSE
and simultaneous 99mTc-sestamibi SPECT. 24 patients
experienced hard cardiac events. During a follow-up of
31 ± 15 months, event rates after both stress modalities
were similar. They concluded that DSE and MPI
Figure 1. Kaplan-Meier survival curves for all-cause mortality using DSE (A) and MPI (B). y
years, MPI myocardial perfusion imaging, DSE dobutamine stress echocardiography.
Figure 2. Kaplan-Meier survival curves for cardiac mortality using DSE (A) and MPI (B). y,
years; MPI, myocardial perfusion imaging; DSE, dobutamine stress echocardiography.
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provided comparable prognostic information. Olmos
et al14 reported a study of 248 patients who underwent
exercise echocardiography and thallium-201 SPECT.
During a mean follow-up of 3.7 ± 2.0 years, 8 nonfatal
infarctions and 7 cardiac deaths occurred. They reported
that exercise echocardiography and thallium-201
SPECT provide comparable prognostic information for
cardiac death and cardiac events. In 146 patients with
previous MI, Acampa et al15 compared the prognostic
value of DSE and SPECT MPI. During a mean follow-
up of 44 ± 19 months, 20 cardiac events occurred.
Ischemia at MPI, but not at echocardiography, was a
significant predictor of cardiac events. Previously, we
reported the 7-year follow-up in these 301 patients. In
that study, patients with normal DSE and MPI main-
tained a relatively low event rate compared to patients
with an abnormal DSE and MPI. Compared to these
previous studies, our study included 301 patients who
were followed for a median time of 14 years. The
present study extends the observations from these
previous studies and demonstrates that the long-term
prognostic value of DSE is similar to that of stress MPI.
A meta-analysis reported higher annualized cardiac
events for patients with normal pharmacological SPECT
(1.78%) compared to patients with normal exercise
SPECT (0.65%).16 Several reasons have been attributed
for these difference; patients who underwent pharma-
cological stress SPECT are older, have more co-
morbidities and has an increased number of risk factors
for CAD. In the current study, we found an annualized
hard cardiac event rate of 1.3% for normal dobutamine
stress MPI. From a clinical perspective, patients unable
to perform exercise tests who have a normal MPI have a
good prognosis and could be spared invasive evaluation
of the coronary arteries. Based on the current findings,
both a normal DSE and a normal stress MPI identified
low- and high-risk patient groups. As a consequence,
both stress modalities could be used interchangeably in
identifying low-risk patient group.
Both DSE and MPI have developed rapidly over the
past years and have emerged as a valuable tool for diagnosis
and prognosis of CAD. These imaging methods have
inherent differences: SPECT probes myocardial hypoper-
fusion, whereas DSE probes systolic dysfunction.13
According to the ischemic cascade, a series of biochemical
reactions that occurs after inadequate myocardial blood
supply, perfusion abnormalities precede systolic dysfunc-
tion.13 This may influence the sensitivity and specificity of
MPI and DSE for the evaluation of myocardial ischemia.
DSE is less sensitive in detecting CAD for mild disease, but
more specific for the overall patient group. Stress SPECT
has a higher diagnostic accuracy in patients with multi-
vessel CAD.17 A recent multicenter study 18 compared
commonly used imaging techniques and found that both
MPI and stress echocardiography had good diagnostic
accuracy for CAD (area under the curve 0.74 and 0.70,
respectively). Our findings show that there are comparable
implications in risk-stratifying patients, using either modal-
ity. Which of these modalities is most suitable still depends
on the patients clinical status, availability, and local
expertise and costs.
This study has some limitations. First, the prognos-
tic value of gated SPECT was not examined, due to the
fact that at the time of data collection gated SPECT was
not routinely performed in our center. As a result left
ventricular ejection fraction (LVEF) was not available.
Also, LVEF was not routinely examined during DSE.
Information about LVEF could have improved the
current analysis. Second, attenuation or scatter correc-
tion during stress SPECT was not routinely performed.
Figure 3. Kaplan-Meier survival curves for hard cardiac events using DSE (A) and MPI (B). y,
years; MPI, myocardial perfusion imaging; DSE, dobutamine stress echocardiography.
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Previous studies have shown that attenuation correction
contribute to optimize further risk stratification.19,20
Third, the patient population was relatively small. This
could have influenced the results.
NEW KNOWLEDGE GAINED
Dobutamine stress echocardiography and dobu-
tamine stress 99mTc-sestamibi SPECT are comparable
in predicting long-term ([14 years) cardiac mortality
and hard cardiac events in high-risk patients (patients
unable to perform exercise testing). From a clinical
view, both techniques can be used interchangeably to
classify patients as low or high risk of cardiac events.
CONCLUSIONS
In this study DSE and MPI provide comparable
prognostic information for the prediction of cardiac
mortality and hard (cardiac mortality and nonfatal MI)
cardiac events in patients unable to perform exercise
testing. Both techniques can be used interchangeably to
classify patients as low or high risk of cardiac events.
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